Exodus Point Capital Management, LP Integra Lifesciences Holdings Corp Transaction History

Exodus Point Capital Management, LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.14 - $34.72 $573,293 - $860,188	24,775 New	24,775 $722,000
Q3 2023 Nov 09, 2023	SELL	$37.8 - $45.97 $525,495 - $639,074	-13,902 Reduced 16.57%	69,989 $2.67 Million
Q2 2023 Aug 10, 2023	BUY	$37.95 - $58.98 $2.01 Million - $3.13 Million	53,049 Added 172.0%	83,891 $3.45 Million
Q1 2023 May 11, 2023	BUY	$52.61 - $60.49 $1.62 Million - $1.87 Million	30,842 New	30,842 $1.77 Million
Q3 2022 Nov 10, 2022	SELL	$42.28 - $57.17 $2.4 Million - $3.25 Million	-56,823 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$53.86 - $66.52 $1.53 Million - $1.89 Million	28,447 Added 100.25%	56,823 $3.07 Million
Q1 2022 May 13, 2022	BUY	$62.86 - $69.24 $1.24 Million - $1.36 Million	19,684 Added 226.46%	28,376 $1.82 Million
Q4 2021 Feb 11, 2022	BUY	$62.47 - $73.25 $542,989 - $636,689	8,692 New	8,692 $582,000
Q3 2021 Nov 15, 2021	SELL	$64.97 - $76.19 $553,089 - $648,605	-8,513 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$66.79 - $76.63 $568,583 - $652,351	8,513 New	8,513 $581,000
Q3 2020 Nov 16, 2020	SELL	$43.33 - $51.72 $298,630 - $356,454	-6,892 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$41.42 - $55.57 $285,466 - $382,988	6,892 New	6,892 $324,000
Q4 2019 Feb 14, 2020	SELL	$55.73 - $62.49 $221,136 - $247,960	-3,968 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$53.29 - $64.59 $211,454 - $256,293	3,968 New	3,968 $238,000
Q2 2019 Aug 14, 2019	SELL	$46.45 - $55.85 $500,127 - $601,336	-10,767 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$42.97 - $57.33 $462,657 - $617,272	10,767 New	10,767 $600,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.